A study on synthesis and upscaling of 2′-o-aecm-5-methyl pyrimidine phosphoramidites for oligonucleotide synthesisShow others and affiliations
2021 (English)In: Molecules, ISSN 1431-5157, E-ISSN 1420-3049, Vol. 26, no 22, article id 6927Article in journal (Refereed) Published
Abstract [en]
2′-O-(N-(Aminoethyl)carbamoyl)methyl-modified 5-methyluridine (AECM-MeU) and 5-methylcytidine (AECM-MeC) phosphoramidites are reported for the first time and prepared in multigram quantities. The syntheses of AECM-MeU and AECM-MeC nucleosides are designed for larger scales (approx. 20 g up until phosphoramidite preparation steps) using low-cost reagents and minimizing chromatographic purifications. Several steps were screened for best conditions, focusing on the most crucial steps such as N3 and/or 2′-OH alkylations, which were improved for larger scale synthesis using phase transfer catalysis (PTC). Moreover, the need of chromatographic purifications was substantially reduced by employing one-pot synthesis and improved work-up strategies. © 2021 by the authors.
Place, publisher, year, edition, pages
MDPI , 2021. Vol. 26, no 22, article id 6927
Keywords [en]
2′-O-(N-(aminoethyl)carbamoyl)methyl modification, 5-methylcytidine, 5-methyluridine, Alkylation, Monoacetylation, Oligonucleotides, Phase transfer catalysis (PTC)
National Category
Organic Chemistry
Identifiers
URN: urn:nbn:se:ri:diva-57339DOI: 10.3390/molecules26226927Scopus ID: 2-s2.0-85119905112OAI: oai:DiVA.org:ri-57339DiVA, id: diva2:1622720
Note
Funding details: Horizon 2020 Framework Programme, H2020, 721613; Funding text 1: Funding: This research was funded by European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement No 721613.
2021-12-232021-12-232024-06-26Bibliographically approved